![]() Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. | ![]() Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | ![]() Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | |
Founding Date | Founding Date 1995 | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees 4742% decrease | Employees 992% decrease | Employees 122 |
Valuation ($) | Valuation ($) 821 k | Valuation ($) 2.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) | Net income ($89m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 168.5m | Total funding raised $ 289.3m |

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company